Comments
Loading...
Plus Therapeutics (PSTV) Forecast
NewsEarningsPlus Therapeutics (PSTV) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPlus Therapeutics (NASDAQ:PSTV) Stock Quotes, Forecast and News Summary
Plus Therapeutics Stock (NASDAQ: PSTV) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Plus Therapeutics (PSTV) stock?
You can purchase shares of Plus Therapeutics (NASDAQ:PSTV) through any online brokerage.
Who are Plus Therapeutics (PSTV) competitors?
Other companies in Plus Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO), Cellectar Biosciences (NASDAQ:CLRB) and T2 Biosystems (NASDAQ:TTOO).
What is the forecast, or price target, for Plus Therapeutics (PSTV) stock?
Plus Therapeutics has a consensus price target of $11.00.
What is the current price for Plus Therapeutics (PSTV)?
The stock price for Plus Therapeutics (NASDAQ: PSTV) is $1.25 last updated January 23, 2025 at 7:54 AM EST.
Does Plus Therapeutics (PSTV) pay a dividend?
There are no upcoming dividends for Plus Therapeutics.
When is Plus Therapeutics (NASDAQ:PSTV) reporting earnings?
Plus Therapeutics’s Q4 earnings are confirmed for Tuesday, March 4, 2025.
Is Plus Therapeutics (PSTV) going to split?
There is no upcoming split for Plus Therapeutics.
What sector and industry does Plus Therapeutics (PSTV) operate in?
Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.